Literature DB >> 15786699

Pro-T ALL: immunophenotypical analyses.

M C Béné1.   

Abstract

Pro-T acute lymphoblastic leukemias (ALL), also called T-I ALL, are extremely rare diseases where cells at the earliest defined stage of T-lineage maturation proliferate in the bone marrow. They are characterized by the absence of all T-lineage differentiation markers except intracytoplasmic CD3 and surface CD7. They may express markers of immaturity and a number of myeloid lineage markers, without reaching the score defining biphenotypic acute leukemia (BAL). A literature search was performed on Medline and the few publications devoted to this disorder are reviewed in this manuscript. Attempts at understanding the mechanisms leading to the development of T-I ALL, based mostly on animal experiments are further presented.

Entities:  

Mesh:

Year:  2004        PMID: 15786699

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  4 in total

1.  The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.

Authors:  P Jain; H Kantarjian; F Ravandi; D Thomas; S O'Brien; T Kadia; J Burger; G Borthakur; N Daver; E Jabbour; M Konopleva; J Cortes; N Pemmaraju; M A Kelly; M Cardenas-Turanzas; R Garris; S Faderl
Journal:  Leukemia       Date:  2013-10-25       Impact factor: 11.528

Review 2.  Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.

Authors:  Adele K Fielding; Lalita Banerjee; David I Marks
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

3.  Adult T Lymphoblastic Leukemia (Pro-T ALL) with Reactive Monocytosis: A Case Report.

Authors:  Rachna Khera; Parul Gautam; Sanjeev Gupta; Prerna Arora; Tejinder Singh; Naresh Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-21       Impact factor: 0.900

4.  Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL).

Authors:  Müge Sayitoğlu; Yücel Erbilgin; Ozden Hatırnaz Ng; Inci Yıldız; Tiraje Celkan; Sema Anak; Omer Devecioğlu; Gönül Aydoğan; Serap Karaman; Nazan Sarper; Cetin Timur; Umit Ure; Uğur Ozbek
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.